LifeSciVC

AUGUST 5, 2024

In 2001, I was at Millennium Pharmaceuticals, one of the major players in the nascent field of genomics drug discovery, and that time has strong parallels to the changing state of drug development today. But that initial quote isn’t from 2024, it is from an interview in 2021 with Mark Levin, CEO at Millennium (MIT Technology Review).

Molecular Biology 90

Molecular Biology Production Drug Development Small Molecule 90

Drug Target Review

MARCH 15, 2024

With more than 20 years of experience in business management, strategy, marketing and product management, Anis also has a research background in biotech, pharmaceutical and premier academic organisations. Anis also serves on the scientific and editorial advisory board of Genetic Engineering News at Mary Ann Liebert, Inc.

Engineering 105

Engineering Molecular Biology Protein Expression Medical Schools 105

Drug Target Review

JUNE 19, 2024

Also, many companies never reached the point where they received validation from big pharmaceutical companies. Mr Culley served on the Board of Orphagen Pharmaceuticals, Inc. He received a BS in biology from Boston College, a masters in biochemistry and molecular biology from the University of California, Santa Barbara, and an M.B.A.

Therapies 84

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 84

Alta Sciences

JUNE 11, 2024

Our experts have over five years of experience with CRISPR gene-editing therapeutics in nonhuman primates (NHPs) and extensive expertise in bioanalysis for biodistribution studies, in addition to many molecular biology platforms , such as ligand binding assays (LBA), NAbs, TAbs, flow cytometry , and ELISpot.

Therapies 52

Therapies Molecular Biology Immune Response Science 52

The Pharma Data

NOVEMBER 18, 2021

Altay Therapeutics, RADD Pharmaceuticals, Rubik Therapeutics, VastBiome and Waypoint Bio to receive free year of lab bench use and other amenities at prominent bioscience incubators. RADD Pharmaceuticals is concentrated on preliminarily undrugged cancer targets. Rubik Rectifiers,co-founded by Murray Robinson,Ph.D.,

Molecular Biology 52

Molecular Biology Pharmaceuticals Laboratories Clinical Development 52

Elrig

APRIL 29, 2024

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Having a combination of computational skills & scientific knowledge such as molecular biology, genomics is also important.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

The Pharma Data

NOVEMBER 10, 2021

“This finding will have a profound impact in the cancer field, as both the pharmaceutical assiduity and exploration labs are putting huge sweats and coffers into searching for and making chemical composites to target Shp2. Myc is a generally detected oncogene, a shifted form of a gene that can beget the growth of cancer cells.

Disease 52

Disease Molecular Biology RNA Drugs 52

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). By geographical region, the global CRO services market in 2023 was dominated by North America. US), Laboratory Corporation of America Holdings (Labcorp) (US), ICON Plc (Ireland), and WuXi AppTec (China).

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

The Pharma Data

SEPTEMBER 15, 2020

Each site has a complete molecular biology core facility that allows companies to do experiments on day one, not year one. We have partnerships with leading pharmaceutical and life-science companies as well as a built-in venture capital firm, Mission BioCapital.

Targeted Protein Degradation 52

Targeted Protein Degradation Molecular Biology Small Molecule Science 52

The Pharma Data

NOVEMBER 19, 2020

The program is being led by Sosei Heptares and progressed in collaboration with multiple companies including Syngene International, Domainex, Fidelta, o2h Discovery, Piramal, WuXi AppTec and the MRC Laboratory of Molecular Biology. Sosei Heptares is headquartered in Tokyo, Japan with corporate and R&D facilities in Cambridge, UK.

Small Molecule 40

Small Molecule Structure Based Drug Design (SBDD) Molecular Biology International 40

Codon

FEBRUARY 13, 2024

3 Another considerable obstacle to pharmaceutical companies’ interest (and investment) is the fact that for a product to be patentable — and therefore profitable — it has to be considered new and inventive. Because frankly, do you know of anything else that can work against multiple drug-resistant bacteria?

Therapies 131

Therapies Virus DNA Clinical Trials 131

Dark Matter Blog

JULY 16, 2021

The only subject in school that held my interest was biology. As soon as I learned about DNA and RNA, I wanted to be a molecular biologist. I wanted to use molecular biology to create drugs. Sir James Black, one of our advisors at Synta, was one of the greatest drug hunters in the history of the pharmaceutical industry.

Small Molecule 52

Small Molecule RNA Clinical Trials DNA 52

The Pharma Data

JANUARY 6, 2021

About CytoDel CytoDel is a privately held biopharmaceutical company that uses the tools of 21st century molecular biology to produce recombinant derivatives of botulinum neurotoxin customized to specific applications.

Science 52

Science Molecular Biology Treatment FDA Approval 52

The Pharma Data

JANUARY 13, 2021

Germany-based Cevec Pharmaceuticals GmbH signed a licensing agreement with Biogen for the use of its proprietary ELEVECTA Technology for the manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications. based Mogrify Limited expanded its research collaboration with MRC Laboratory of Molecular Biology.

Licensing 52

Licensing Licensing Clinical Trials Vaccine 52

The Pharma Data

SEPTEMBER 17, 2020

About Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI). Academic Press.

Vaccine 52

Vaccine Virus Clinical Trials Immune Response 52

The Pharma Data

JANUARY 21, 2021

Regeneron Pharmaceuticals, Inc. SOURCE Regeneron Pharmaceuticals, Inc. and WASHINGTON , Jan. 21, 2021 /PRNewswire/ — Finalists to Compete for More Than $1.8 Million in Oldest and Most Prestigious U.S. STEM Competition for High School Seniors. Over $3 Million Awarded Throughout Competition. Society for Science. Source link.

Science 40

Science Engineering Molecular Biology Bioinformatics 40

Drug Target Review

APRIL 8, 2024

Dr Cote began his career at the University of Southern California Keck School of Medicine, rising to Professor in departments of Pathology and Urology and Director in the Genitourinary Cancer Program, Laboratory of Immunology and Molecular Pathology and USC Biomedical Nanoscience Initiative. In 2009, he became the Joseph R. Coulter Jr.

Hospitals 52

Hospitals Therapies Clinical Trials Molecular Biology 52

Codon

JUNE 18, 2024

Even after a half-century of molecular biology research, scientists didn’t know until recently how gas vesicles physically trap gas while occluding water. angstroms, or roughly twice the length of a single carbon-carbon bond. This could transform medicine.

Engineering 70

Engineering Laboratories International Clinical Trials 70

Codon

JUNE 26, 2023

Future Nobel Laureate, Paul Berg, narrated the video, which quickly became a cult classic moment in molecular biology history. … There was a time when the film was being shown in biology courses from middle school to graduate courses in genetics and biochemistry and even in post graduate education lectures to physicians.

DNA 52

DNA Therapies Engineering Clinical Trials 52

Codon

JUNE 26, 2023

Future Nobel Laureate, Paul Berg, narrated the video, which quickly became a cult classic moment in molecular biology history. … There was a time when the film was being shown in biology courses from middle school to graduate courses in genetics and biochemistry and even in post graduate education lectures to physicians.

DNA 52

DNA Therapies Engineering Clinical Trials 52

Codon

JANUARY 5, 2025

Some field strategists — such as Salvador Luria, in the case of molecular biology — have a warm personality that draws individuals into a field. With the construction of the pilot plant, Cohn built a scientific environment at Harvard that mimicked commercial pharmaceutical factories in one fell swoop.

Laboratories 94

Laboratories Science Production Research 94

Drug Target Review

DECEMBER 9, 2024

Moving through leadership roles at pharmaceutical giants like Merck & Co., Women are underrepresented in top executive positions, particularly in biotech and pharmaceutical companies. Initially, I started as a scientist and healthcare provider, focusing on creating innovative solutions that have a direct impact on patient health.

Therapies 52

Therapies Disease Molecular Biology Pharmaceuticals 52

Codon

JANUARY 8, 2025

A Brief History of Ibuprofen ( The Pharmaceutical Journal ) The $100 Electron Microscope Manu Prakash, a bioengineering professor at Stanford University, is trying to build a $100 electron microscope — a machine that can cost millions ! How, exactly, might one turn the ship around and reinvigorate science?

Science 62

Science Vaccine Engineering Disease 62

The Pharma Data

DECEMBER 2, 2020

The pharmaceutical industry has battled COVID-19 since the moment members learned of it. declared war on COVID and sacrificed large swathes of its economy to prevent the spread of this dreaded disease. Although the Agency has a staff of about 17,000, “It can’t have experts for every single disease,” Durbin said.

Vaccine 52

Vaccine FDA Molecular Biology Licensing 52